Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accelerometry: Improving Objective Assessments of Therapeutic Impact in Pediatric Pulmonary Arterial Hypertension.

Literature DB >> 28707968

Accelerometry: Improving Objective Assessments of Therapeutic Impact in Pediatric Pulmonary Arterial Hypertension.

Eric D Austin¹, Jeffrey A Feinstein².

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 28707968 PMCID： PMC5519973 DOI： 10.1164/rccm.201702-0409ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

Keyword Cloud
References

× No keyword cloud information.

16 in total

1. Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors: Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal: JAMA Date: 2003-05-21 Impact factor: 56.272

2. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

Authors: Georg Hansmann; Christian Apitz; Hashim Abdul-Khaliq; Tero-Pekka Alastalo; Phillip Beerbaum; Damien Bonnet; Karl-Otto Dubowy; Matthias Gorenflo; Alfred Hager; Anne Hilgendorff; Michael Kaestner; Martin Koestenberger; Juha W Koskenvuo; Rainer Kozlik-Feldmann; Titus Kuehne; Astrid E Lammers; Heiner Latus; Ina Michel-Behnke; Oliver Miera; Shahin Moledina; Vivek Muthurangu; Joseph Pattathu; Dietmar Schranz; Gregor Warnecke; Peter Zartner
Journal: Heart Date: 2016-05 Impact factor: 5.994

3. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.

Authors: Mark-Jan Ploegstra; Sanne Arjaans; Willemljn M H Zijlstra; Johannes M Douwes; Theresia R Vissia-Kazemier; Marcus T R Roofthooft; Hans L Hillege; Rolf M F Berger
Journal: Chest Date: 2015-09 Impact factor: 9.410

4. Validity of ActiGraph 2-regression model, Matthews cut-points, and NHANES cut-points for assessing free-living physical activity.

Authors: Scott E Crouter; Diane M DellaValle; Jere D Haas; Edward A Frongillo; David R Bassett
Journal: J Phys Act Health Date: 2012-09-11

5. Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.

Authors: Willemijn M H Zijlstra; Mark-Jan Ploegstra; Theresia Vissia-Kazemier; Marcus T R Roofthooft; Gideon du Marchie Sarvaas; Beatrijs Bartelds; Annette Rackowitz; Freek van den Heuvel; Hans L Hillege; Guy Plasqui; Rolf M F Berger
Journal: Am J Respir Crit Care Med Date: 2017-07-15 Impact factor: 21.405

6. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors: David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal: Chest Date: 2009-10-16 Impact factor: 9.410

7. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Authors: Steven H Abman; Georg Hansmann; Stephen L Archer; D Dunbar Ivy; Ian Adatia; Wendy K Chung; Brian D Hanna; Erika B Rosenzweig; J Usha Raj; David Cornfield; Kurt R Stenmark; Robin Steinhorn; Bernard Thébaud; Jeffrey R Fineman; Titus Kuehne; Jeffrey A Feinstein; Mark K Friedberg; Michael Earing; Robyn J Barst; Roberta L Keller; John P Kinsella; Mary Mullen; Robin Deterding; Thomas Kulik; George Mallory; Tilman Humpl; David L Wessel
Journal: Circulation Date: 2015-11-03 Impact factor: 29.690